TITLE

Ileal interposition reduces blood glucose levels and decreases insulin resistance in a type 2 diabetes mellitus animal model by up-regulating glucagon-like peptide-1 and its receptor

AUTHOR(S)
Xu Sun; Meizhu Zheng; Maomin Song; Rixing Bai; Shi Cheng; YingXing; Huisheng Yuan; Pilin Wang
PUB. DATE
July 2014
SOURCE
International Journal of Clinical & Experimental Pathology;2014, Vol. 7 Issue 7, p4136
SOURCE TYPE
Academic Journal
DOC. TYPE
Article
ABSTRACT
No abstract available.
ACCESSION #
97436072

 

Related Articles

  • Myocardial Insulin Signaling and Glucose Transport Are Up-regulated in Goto-Kakizaki Type 2 Diabetic Rats After Ileal Transposition. Yan, Zhibo; Chen, Weijie; Liu, Shaozhuang; Zhang, Guangyong; Sun, Dong; Hu, Sanyuan // Obesity Surgery;Mar2012, Vol. 22 Issue 3, p493 

    Background: Ileal transposition (IT) as one of the effective treatments for non-obese type 2 diabetes mellitus has been widely investigated. However, the mechanisms underlying profound improvements in glucose homeostasis are still uncertain. Our objective was to explore the myocardial insulin...

  • Improved Glucose Metabolism In Vitro and In Vivo by an Allosteric Monoclonal Antibody That Increases Insulin Receptor Binding Affinity. Corbin, John A.; Bhaskar, Vinay; Goldfine, Ira D.; Bedinger, Daniel H.; Lau, Angela; Michelson, Kristen; Gross, Lisa M.; Maddux, Betty A.; Kuan, Hua F.; Tran, Catarina; Lao, Llewelyn; Handa, Masahisa; Watson, Susan R.; Narasimha, Ajay J.; Zhu, Shirley; Levy, Raphael; Webster, Lynn; Wijesuriya, Sujeewa D.; Liu, Naichi; Wu, Xiaorong // PLoS ONE;Feb2014, Vol. 9 Issue 2, p1 

    Previously we reported studies of XMetA, an agonist antibody to the insulin receptor (INSR). We have now utilized phage display to identify XMetS, a novel monoclonal antibody to the INSR. Biophysical studies demonstrated that XMetS bound to the human and mouse INSR with picomolar affinity....

  • Exendin-4 Ameliorates Traumatic Brain Injury-Induced Cognitive Impairment in Rats. Eakin, Katharine; Li, Yazhou; Chiang, Yung-Hsiao; Hoffer, Barry J.; Rosenheim, Hilary; Greig, Nigel H.; Miller, Jonathan P. // PLoS ONE;Dec2013, Vol. 8 Issue 12, p1 

    Traumatic brain injury represents a major public health issue that affects 1.7 million Americans each year and is a primary contributing factor (30.5%) of all injury-related deaths in the United States. The occurrence of traumatic brain injury is likely underestimated and thus has been termed...

  • Basic Science - Diabetes.  // Current Medical Literature: Diabetes;2009, Vol. 26 Issue 1, p30 

    The article presents abstracts of medical research on diabetes including "Role of Central Nervous System Glucagon-like Peptide-1 Receptors in Enteric Glucose Sensing," "Brain Glucagon-like Peptide-1 Regulates Arterial Blood Flow, Heart Rate and Insulin Sensitivity" and "Changes in Transferrin...

  • Maternal Ileal Interposition Surgery Confers Metabolic Improvements to Offspring Independent of Effects on Maternal Body Weight in UCD-T2DM Rats. Cummings, Bethany P.; Graham, James L.; Stanhope, Kimber L.; Chouinard, Michael L.; Havel, Peter J. // Obesity Surgery;Dec2013, Vol. 23 Issue 12, p2042 

    Background: Increasing numbers of people are undergoing bariatric surgery, of which approximately half are women in their childbearing years. However, information on the long-term effects of maternal bariatric surgery in their children is lacking. Furthermore, since bariatric surgery is...

  • Off-Label Use of Liraglutide in the Management of a Pediatric Patient with Type 2 Diabetes Mellitus. Micale, Sara J.; Kane, Michael P.; Hogan, Eileen // Case Reports in Pediatrics;2013, p1 

    Liraglutide is a glucagon-like peptide 1 (GLP-1) analog indicated for the treatment of type 2 diabetes mellitus as an adjunct to diet and exercise in adults. Liraglutide lowers blood glucose levels by stimulating insulin secretion and decreasing glucagon release in glucose-dependent manners,...

  • Roux-en-Y Gastric Bypass-Induced Improvement of Glucose Tolerance and Insulin Resistance in Type 2 Diabetic Rats Are Mediated by Glucagon-Like Peptide-1. Liu, Yuan; Zhou, Yong; Wang, Yong; Geng, Donghua; Liu, Jingang // Obesity Surgery;Sep2011, Vol. 21 Issue 9, p1424 

    Background: The aim of this study was to investigate the effects of Roux-en-Y gastric bypass (RYGB) on glucose tolerance and insulin resistance in type 2 diabetic rats and the possible mechanisms involved in this process. Methods: Thirty Goto-Kakizaki (GK) rats were randomly divided into three...

  • Lipotoxicity impairs incretin signalling. Poitout, V. // Diabetologia;Feb2013, Vol. 56 Issue 2, p231 

    The incretin hormones glucagon-like peptide-1 and glucose-dependent insulinotropic peptide are secreted by enteroendocrine cells and augment glucose-induced insulin secretion in response to food ingestion in a glucose-dependent manner. This mechanism forms the basis for incretin-based therapies...

  • Small Molecule Activators of the Insulin Receptor: Potential New Therapeutic Agents for the Treatment of Diabetes Mellitus. Laborde, Edgardo; Manchem, Vara Prasad // Current Medicinal Chemistry;Dec2002, Vol. 9 Issue 24, p2231 

    Diabetes mellitus refers to a spectrum of syndromes characterized by abnormally high levels of glucose in blood. These syndromes are associated with an absolute (Type 1 diabetes) or relative (Type 2 diabetes) deficiency of insulin, coupled with varying degrees of peripheral resistance to the...

  • AN OVERVIEW OF INCRETIN HORMONES. Holst, Jens J.; Lasalle, James R. // Journal of Family Practice;Sep2008 Supplement, Vol. 57, pS4 

    The article discusses the understanding about the role of incretin hormones in type 2 diabetes mellitus (T2DM). It explores the T2DM which results from a complex pathophysiologic process including pancreatic alpha and beta cell dysfunction, peripheral insulin resistance and impaired function of...

Share

Read the Article

Courtesy of THE LIBRARY OF VIRGINIA

Sorry, but this item is not currently available from your library.

Try another library?
Sign out of this library

Other Topics